Immunova
Clinical-stage oncology company developing nanotechnology-enabled therapeutics designed to engage multiple targets simultaneously and advance candidate medicines into clinical development.
Industries
Biotechnology
Nanotechnology
Oncology
Pharmaceutical
Nr. of Employees
small (1-50)
Products
Immunova Proprietary Nanotechnology Platform
Clinical stage oncology platform utilizing proprietary nanotechnology to develop first-in-class medicines capable of attacking multiple targets at once.
Immunova Proprietary Nanotechnology Platform
Clinical stage oncology platform utilizing proprietary nanotechnology to develop first-in-class medicines capable of attacking multiple targets at once.
Expertise Areas
- Oncology drug development
- Clinical development (clinical-stage programs)
- Nanotechnology-enabled therapeutics
- Multi-target therapeutic strategies
Key Technologies
- Nanotechnology
- Multi-target therapeutic design
- Targeted drug delivery